After 16 weeks of HFDs, the researchers found that CD1dKO mice were protected against obesity and NASH progression, and CD8+ T-cell-depleted mice were also protected from NASH while continuing to result in weight gain. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.